Table 1 List of outcome measures
| Â | Group 1 | Group 2 | Group 3 | Group 4 |
|---|---|---|---|---|
Outcome group | Glycaemic control evaluation outcomes | Macrovascular complications preventive measures outcomes | Microvascular complications preventive measures outcomes | Economic evaluation outcomes |
Main outcome | Proportion of patients who were prescribed 3 measurements of glycosilated haemoglobin with at least two months' interval | Proportion of patients who were prescribed all macrovascular complications assessment tests (1) | Proportion of patients who were prescribed all microvascular complications assessment tests (2) | Marginal cost per each glycosilated haemoglobin measurement |